Relations of plasma fibrinogen level in children to measures of obesity, the (G-455→A) mutation in the β-fibrinogen promoter gene, and family history of ischemic heart disease: The Columbia University BioMarkers Study

American Journal of Epidemiology

Volumn 150, Issue 7, 1999, Pages 737-746

  Shea, Steven ^a,b   Isasi, Carmen R ^a,b   Couch, Sarah ^a   Starc, Thomas J ^a   Tracy, Russell P ^c   Deckelbaum, Richard ^a   Talmud, Philippa ^d   Berglund, Lars ^a   Humphries, Steve E ^d  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Atherosclerosis; Cardiovascular diseases; Child; Fibrinogen; Genetics; Obesity

Indexed keywords

BLOOD CLOTTING FACTOR;

ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHILD; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNOLOGY; FIBRINOGEN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENETIC PREDISPOSITION; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; OBESITY; PROMOTER REGION; REGRESSION ANALYSIS; SKINFOLD;

EID: 0033214130     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010076     Document Type: Article

References (33)

1. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980;303:897-902.
2. Laffel GL, Braunwald E. Thrombolytic therapy: a new strategy for the treatment of acute myocardial infarction (1). N Engl J Med 1984;311:710-17.
3. Fibrinolytytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
4. Wilhelmsen L, Svardsudd K, Korsan-Bengsten B, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-5.
5. Meade TW, Mellows S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986;2:533-7.
6. Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease: The Framingham Study. JAMA 1987;258:1183-6.
7. Heinrich J, Balleisen L, Schulte H, et al. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14:54-9.
8. Folsom AR, Wu KK, Rosamond WD, et al. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997;96:1102-8.
9. Carter AM, Catto AJ, Bamford JM, et al. Gender-specific associations of the fibrinogen B β 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease. Arterioscler Thromb Vasc Biol 1997;17:589-94.
10. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol 1980;112:564-9.
11. Bao W, Srinivasan SR, Berenson GS. Plasma fibrinogen and its correlates in children from a biracial community: The Bogalusa Heart Study. Pediatr Res 1993;33:323-6.
12. Cacciari E, Balsamo A, Palareti G, et al. Haemorheologic and fibrinolytic evaluation in obese children and adolescents. Eur J Pediatr 1988;147:381-4.
13. Sanchez-Bayle M, Cocho P, Baeza J, et al. Fibrinogen as a cardiovascular risk factor in Spanish children and adolescents. The Niño Jesus Group. Am Heart J 1993;126:322-6.
14. Ferguson MA, Gutin B, Owen S, et al. Fat distribution and hemostatic measures in obese children. Am J Clin Nutr 1998; 67:1136-40.
15. Roy SN, Mukhopadhyay G, Redman CM. Regulation of fibrinogen assembly: transfection of Hep G2 cells with B β cDNA specifically enhances synthesis of the three component chains of fibrinogen. J Biol Chem 1990;265:6389-93.
16. Thomas AE, Green FR, Kelleher CH, et al. Variation in the promoter region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers. Thromb Haemost 1991;65:487-90.
17. Green F, Hamsten A, Blomback M, et al. The role of the β-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden. Thromb Haemost 1993;70:915-20.
18. Scarabin P-Y, Bara L, Ricard S, et al. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction: The ECTIM Study. Arterioscler Thromb 1993;13:886-91.
19. -455→A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 1995; 15:96-104.
20. Behague I, Poirier O, Nicaud V, et al. β-Fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction: The ECTIM Study. Cas-Temoins sur l'Infarctus du Myocarde. Circulation 1996;93:440-9.
21. -455→A) in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease: a study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Invest 1997;99: 3034-9.
22. Bureau of the Census. Summary tape file 3 - CD-ROM technical documentation. Appendix B. Definitions of subject characteristics. Washington, DC: US Department of Commerce, Economics, and Statistics, 1992.
23. Gutin B, Basch C, Shea S, et al. Blood pressure, fitness, and fatness in 5- and 6-year-old children. JAMA 1990;264:1123-7.
24. Lohman TG, Roche AF, Martorell R, eds. Anthropometric standardization reference manual. Champagne, IL: Human Kinetics Books, 1988.
25. Geffken DF, Keating FG, Kennedy MH, et al. The measurement of fibrinogen in population-based research: studies on instrumentation and methodology. Arch Pathol Lab Med 1994;118:1106-9.
26. +1689 (AvaII), and BclI, (β-fibrinogen) and TaqI (α-fibrinogen), and their detection by PCR. Hum Mutat 1994;3:79-81.
27. Huber P, Laurent M, Dalmon J. Human β-fibrinogen gene expression: upstream sequences involved in its tissue specific expression and its dexamethasone and interleukin 6 stimulation. J Biol Chem 1990;265:5695-701.
28. Dalmon J, Laurent M, Courtois G. The human β-fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6-responsive element. Mol Cell Biol 1993;13:1183-93.
29. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997;82:4916-200.
30. Meilahn EN, Cauley JA, Tracy RP, et al. Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women. Am J Epidemiol 1996;143: 159-66.
31. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987;2:986-8.
32. Sorlie PD, Backlund E, Johnson JJ, et al. Mortality by Hispanic status in the United States. JAMA 1993;270:2464-8.
33. Public Health Service, US Department of Health and Human Services. Healthy People 2000: national health promotion and disease prevention objectives. Washington, DC: US GPO, 1991:34-48. (DHHS publication no. (PHS) 91-50212).